Forte Biosciences, Inc. (FBRX) Free cash flow 2016–2025
Forte Biosciences, Inc. (FBRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.0MFY2025 · since FY2016: -$30.1M → -$51.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.0M | -65.7% |
| FY2024 | -$30.8M | -6.9% |
| FY2023 | -$28.8M | — |
| FY2019 | -$2.9M | +92.0% |
| FY2018 | -$36.4M | -14.6% |
| FY2017 | -$31.8M | -5.7% |
| FY2016 | -$30.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice